Cargando…
Methimazole-induced cholestatic hepatitis: two cases report and literature review
Methimazole is commonly prescribed for patients who are thyrotoxic. Cholestatic hepatitis is a rare but serious adverse event which may be associated with interventional therapy. In this case report, we present two Chinese women with cholestatic jaundice due to methimazole treatment. Both patients h...
Autores principales: | Zou, Hai, Jin, Lie, Wang, Li-Ren, Braddock, Martin, Cai, Wen-Wei, Zheng, Ming-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826268/ https://www.ncbi.nlm.nih.gov/pubmed/26498145 http://dx.doi.org/10.18632/oncotarget.6144 |
Ejemplares similares
-
Case report: Severe cholestatic jaundice associated with hyperthyroidism treated with methimazole
por: Liu, Xiaoqiang, et al.
Publicado: (2023) -
A Case Report on Methimazole-Induced Cholestatic Jaundice in an Elderly Man With Hyperthyroidism
por: Ng, Jennifer Lourdes, et al.
Publicado: (2021) -
Rash and cholestatic liver injury caused by methimazole in a woman with Turner syndrome and Graves’s disease: a case report and literature review
por: Zeng, Jinhui, et al.
Publicado: (2021) -
A rare case of methimazole-induced cholestatic jaundice in an elderly man of Asian ethnicity with hyperthyroidism: A case report
por: Ji, Hongjian, et al.
Publicado: (2017) -
Methimazole-induced myositis: a case report and review of the literature
por: Bou Khalil, R, et al.
Publicado: (2013)